Breaking News Instant updates and real-time market news.

CRBP

Corbus Pharmaceuticals

$8.25

0.45 (5.77%)

07:38
11/29/16
11/29
07:38
11/29/16
07:38

Corbus commencing one-year open-label extension to Resunab phase 2 study

Corbus Pharmaceuticals announced that it is commencing a one-year, open-label extension study of the ongoing Phase 2 clinical study of Resunab, JBT-101, for the treatment of skin-predominant dermatomyositis. This open-label extension was submitted to and reviewed by the U.S. FDA. The goal of the open-label extension dermatomyositis study is to provide all enrolled subjects with the option of receiving JBT-101 for one year after they complete the four-month, double-blind placebo controlled portion of the study and to collect long-term safety and efficacy on JBT-101. The safety and efficacy endpoints used in the double-blinded, placebo-controlled portion of the study will be assessed throughout the one year extension study. The Phase 2 study in skin-predominant dermatomyositis is funded by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health to the University of Pennsylvania School of Medicine.

CRBP Corbus Pharmaceuticals
$8.25

0.45 (5.77%)

09/19/16
AGIS
09/19/16
NO CHANGE
Target $12
AGIS
Buy
Corbus Pharmaceuticals price target raised to $12 from $7 at Aegis
Aegis analyst Robert Leboyer raised his price target for Corbus Pharmaceuticals to $12 from $7 and keeps a Buy rating on the name.
10/04/16
CANT
10/04/16
INITIATION
Target $17
CANT
Buy
Corbus Pharmaceuticals initiated with a Buy at Cantor
Cantor initiated Corbus Pharmaceuticals with a Buy and a $17 price target.
10/25/16
NBLE
10/25/16
NO CHANGE
NBLE
Corbus Pharmaceuticals risk/reward remains favorable, says Noble Financial
Noble Financial analyst Kumaraguru Raja remains bullish on Corbus' Resunab being developed for treating inflammation and fibrosis as it preferentially targets CB2 receptor; saying preliminary positive data in healthy volunteers validates role in inflammation resolution. The analyst said Resunab has better anti-inflammatory activity even in low doses adn the open-label extension indicates the FDA comfort with safety and efficacy. Raja likes Corbus' risk/reward heading into multiple data readouts and reiterates his Buy rating and $19 price target on shares.
11/15/16
JMPS
11/15/16
NO CHANGE
JMPS
Corbus Pharmaceuticals price target raised to $20 from $9 at JMP Securities
JMP Securities analyst Liisa Bayko raised her price target on Corbus as she believes that data on the company's Resunab drug for scleroderma indicates that its efficacy could be significantly positive, while its safety/tolerability could be "favorable." Bayko keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

BWLD

Buffalo Wild Wings

$170.85

2.75 (1.64%)

09:08
12/06/16
12/06
09:08
12/06/16
09:08
Hot Stocks
Marcato launches dedicated website to express views on Buffalo Wild Wings »

Marcato Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.99

0.9 (1.21%)

, DGII

Digi International

$13.65

0.1 (0.74%)

09:07
12/06/16
12/06
09:07
12/06/16
09:07
Hot Stocks
Breaking Hot Stocks news story on Belden, Digi International »

Belden…

BDC

Belden

$74.99

0.9 (1.21%)

DGII

Digi International

$13.65

0.1 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$13.03

0.09 (0.70%)

09:06
12/06/16
12/06
09:06
12/06/16
09:06
Initiation
Huntington Bancshares initiated  »

Huntington Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

BDC

Belden

$74.99

0.9 (1.21%)

, DGII

Digi International

$13.65

0.1 (0.74%)

09:06
12/06/16
12/06
09:06
12/06/16
09:06
Hot Stocks
Breaking Hot Stocks news story on Belden, Digi International »

Belden: Offer for Digi…

BDC

Belden

$74.99

0.9 (1.21%)

DGII

Digi International

$13.65

0.1 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.99

0.9 (1.21%)

, DGII

Digi International

$13.65

0.1 (0.74%)

09:05
12/06/16
12/06
09:05
12/06/16
09:05
Hot Stocks
Belden: Digi management, board 'unwilling' to engage in discussions with Belden »

Notes…

BDC

Belden

$74.99

0.9 (1.21%)

DGII

Digi International

$13.65

0.1 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCE.A

Forest City

$18.75

0.45 (2.46%)

, FCE.B

Forest City

$19.25

0.56 (3.00%)

09:05
12/06/16
12/06
09:05
12/06/16
09:05
Hot Stocks
Forest City recommends shareholders to eliminate dual-class share structure »

Forest City Realty Trust…

FCE.A

Forest City

$18.75

0.45 (2.46%)

FCE.B

Forest City

$19.25

0.56 (3.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.99

0.9 (1.21%)

, DGII

Digi International

$13.65

0.1 (0.74%)

09:05
12/06/16
12/06
09:05
12/06/16
09:05
Hot Stocks
Belden reiterates $13.82 per share offer to Digi International board »

Belden (BDC) announced…

BDC

Belden

$74.99

0.9 (1.21%)

DGII

Digi International

$13.65

0.1 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BW

Babcock & Wilcox

$15.99

0.46 (2.96%)

09:04
12/06/16
12/06
09:04
12/06/16
09:04
Hot Stocks
B&W names D. Paul Scavuzzo Chief Commercial Officer »

Babcock & Wilcox…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

XPLR

Xplore Technologies

$2.31

-0.0124 (-0.53%)

09:04
12/06/16
12/06
09:04
12/06/16
09:04
Hot Stocks
Xplore Technologies receives second rugged tablet follow-on order »

Xplore Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

BA

Boeing

$152.16

-0.09 (-0.06%)

09:03
12/06/16
12/06
09:03
12/06/16
09:03
Periodicals
Trump wants to cancel Boeing Air Force One order »

President-elect Donald…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLJ

RLJ Lodging Trust

$23.38

0.86 (3.82%)

09:03
12/06/16
12/06
09:03
12/06/16
09:03
Hot Stocks
RLJ Lodging Trust announces sale of two hotels in NYC for $286M »

RLJ Lodging Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEIC

SEI Investments

$48.16

1.2 (2.56%)

09:03
12/06/16
12/06
09:03
12/06/16
09:03
Hot Stocks
SEI Investments signs three-year contract extension with Veritas Investment »

SEI UK Private Banking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUE

Nucor

$65.10

2.07 (3.28%)

09:02
12/06/16
12/06
09:02
12/06/16
09:02
Hot Stocks
Nucor to acquire Southland Tube for $130M »

Nucor announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSTX

Mast Therapeutics

$0.08

0.0009 (1.08%)

09:01
12/06/16
12/06
09:01
12/06/16
09:01
Hot Stocks
Mast Therapeutics enrolls first patient in Phase 2 study of AIR001 »

Mast Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNSL

Consolidated Communications

$27.21

-1.17 (-4.12%)

09:01
12/06/16
12/06
09:01
12/06/16
09:01
Upgrade
Consolidated Communications rating change  »

Consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NLSN

Nielsen

$42.41

0.34 (0.81%)

09:01
12/06/16
12/06
09:01
12/06/16
09:01
Conference/Events
Nielsen to host 2016 analyst day »

2016 Analyst Day to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

CMG

Chipotle

$396.27

-3.76 (-0.94%)

09:00
12/06/16
12/06
09:00
12/06/16
09:00
Hot Stocks
Chipotle says sales haven't recovered as much as previously expected »

Says "took eye off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

RGSE

Real Goods Solar

$0.51

0.0596 (13.23%)

09:00
12/06/16
12/06
09:00
12/06/16
09:00
Syndicate
Breaking Syndicate news story on Real Goods Solar »

Real Goods Solar files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
12/06/16
12/06
09:00
12/06/16
09:00
General news
U.S. trade deficit widened 17.8% to -$42.6 B in October »

U.S. trade deficit…

REI

Ring Energy

$12.15

-0.81 (-6.25%)

08:59
12/06/16
12/06
08:59
12/06/16
08:59
Syndicate
Ring Energy 6.5M share Spot Secondary priced at $11.50 »

SunTrust and Seaport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NSTG

NanoString

$21.99

-0.15 (-0.68%)

08:59
12/06/16
12/06
08:59
12/06/16
08:59
Recommendations
NanoString analyst commentary  »

NanoString a top growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

T

AT&T

$38.63

0.02 (0.05%)

, TWX

Time Warner

$93.34

-0.46 (-0.49%)

08:57
12/06/16
12/06
08:57
12/06/16
08:57
Hot Stocks
AT&T CEO says Time Warner review should be 'straightforward' »

Says Time Warner (TWX)…

T

AT&T

$38.63

0.02 (0.05%)

TWX

Time Warner

$93.34

-0.46 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

08:56
12/06/16
12/06
08:56
12/06/16
08:56
General news
Redbook Store Sales data reported »

Week of 12/3 Redbook…

TDOC

Teladoc

$18.45

0.5 (2.79%)

08:55
12/06/16
12/06
08:55
12/06/16
08:55
Hot Stocks
Teladoc says reached 100,000 telehealth visits during November »

Teladoc announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$21.84

0.61 (2.87%)

, AAPL

Apple

$109.11

-0.79 (-0.72%)

08:55
12/06/16
12/06
08:55
12/06/16
08:55
Options
Notable open interest changes for December 6th »

Monday's total…

BAC

Bank of America

$21.84

0.61 (2.87%)

AAPL

Apple

$109.11

-0.79 (-0.72%)

RAD

Rite Aid

$8.06

0.05 (0.62%)

F

Ford

$12.44

0.2 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 05

    Jan

  • 10

    Jan

  • 13

    Jan

  • 13

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.